| |||||||
| Register | FAQ | Gaming | VB Image Host | Search | Today's Posts | Mark Forums Read |
| | LinkBack | Thread Tools | Display Modes |
| | #1 |
| Unf*ckwit'able ![]() ![]() ![]() Join Date: Nov 2004
Posts: 3,872
Grams: 21,643.55 Groans: 3
Groaned at 6 Times in 6 Posts
Thanks: 704
Thanked 853 Times in 501 Posts
| http://www.guardian.co.uk/business/s...366371,00.html Looks like the drug regulation boards advised GW to focus their trials on the drug's ability to reduce muscle spasms in MS sufferers...and then told them that the trials weren't concrete enough to justify anything. "...it decided to choose one particular clinical trial to put in front of the regulators, which tested the drug's reduction of muscle spasms. This is hard to measure objectively, but GW said it focused on this because it was advised to by UK regulators. The CSM told GW that that the data might not be 'clinically relevant'." All the other trials GW Pharmaceuticals conducted support the drug's effectiveness, so why are they focusing on such a circumstantial one? This all comes a week before Home Office and Department of Health MPs meet to discuss concerns that MS sufferers are buying cannabis off the street...:GOD FORBID:...and the company is looking to them to sell it unlicensed. In other words, without the support of regulatory entities like the CSM, which was founded in light of the thalidomide ****up. There have been talks on making the organisation more 'transparent'. God knows what that means though. It all comes to the sloathful British approach to medicine and pretty much anything else, although I do not question political motivations in Sativex's rejection. Looks like the rest of the world will benefit from the research long before we will here.
__________________ SWP ![]() "I'm not into this detail stuff. I'm more concepty." -- "If I know the answer I'll tell you the answer, and if I don't, I'll just respond, cleverly." -- "Secretary Powell and I agree on every single issue that has ever been before this administration except for those instances where Colin's still learning." -- "As we know, there are known knowns; there are things we know we know. We also know there are known unknowns; that is to say we know there are some things we do not know. But there are also unknown unknowns: the ones we don't know we don't know." |
| | |
| Marijuana.com Sponsor | |
Advertisement | |
| | #2 |
| Don't loose hope just yet GW has put a great deal of money into it's research and design of Sativex...one small hurdle is not going to stop them -- in fact, it will allow them to streamline the process for authorization bacuse they will now know where the "naysaying naybobs of negativity" will be fighting against their production and $ale of the product. Hang on and again...don't loose hope | |
| |
| | #3 |
| New Member Join Date: Feb 2005
Posts: 1
Grams: 573.20 Groans: 0
Groaned at 0 Times in 0 Posts
Thanks: 0
Thanked 0 Times in 0 Posts
| I have been diagnosed with ms last year and i smoke mj for some of the numbness. it does seem to help also with the mood swings. i wisht this would be legalized. i don't think that smoking pot is any worse than getting drunk, in fact it's alot better. my husband does not smoke, but he does agree that it helps me with my ms. just wanted to let someone know. thanks. ![]() |
| | |
| | #4 |
| Keep the Faith.... And keep an eye on Montel Williams -- he is doing a lot to educate the public on the use of MJ for MS. Have a cookie and welcome to the site Hugz, Mama Budz | |
| |
| Marijuana.com Sponsor | |
Advertisement | |